Qual é o preço para Excelsior Biopharma Inc. (6496)

O preço para Excelsior Biopharma Inc. (6496) é $0.7949757

Qual é a capitalização de mercado para Excelsior Biopharma Inc. (6496)

A capitalização de mercado para Excelsior Biopharma Inc. (6496) é $36.94M

Excelsior Biopharma Inc. (6496) Índice P/V

Excelsior Biopharma Inc., established in 1988 and headquartered in Taipei, Taiwan, functions as a pharmaceutical enterprise with a global market presence, encompassing Taiwan, China, and other international regions. The company offers a comprehensive range of healthcare solutions, including prescription and over-the-counter medications, medical devices, nutritional supplements, and various medical supplies. Excelsior addresses numerous therapeutic areas such as pediatrics, gastroenterology, neurology, cardiology, dermatology, medical toxicology, dentistry, obstetrics, oncology, hematology, otorhinolaryngology, and infectious disease management. Its product line also features specialized diagnostic kits under the Actim brand for identifying conditions like influenza virus, fecal occult blood, acute pancreatitis, and for assessing preterm or full-week delivery and early membrane rupture. Moreover, the company provides oral hygiene products, including toothpaste, mouthwash, and gels, under the Oral7 name. Beyond product sales, Excelsior is involved in the import and export of active pharmaceutical ingredients, as well as engaging in technological research, facilitating pharmaceutical technology transfer, and participating in collaborative development and improvement initiatives. The company adopted its current name, Excelsior Biopharma Inc., in June 2003, having previously been known as Excelsior Enterprise Co., Ltd.

Ano	Rácio P/S	Alterar
Não há dados suficientes para as datas fornecidas.

Ano

Rácio P/S

Alterar

Não há dados suficientes para as datas fornecidas.

Empresa	Rácio P/S	Diferença do rácio P/S	País
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	7.73	-	IN

Empresa

Rácio P/S

Diferença do rácio P/S

País